134 related articles for article (PubMed ID: 23670648)
1. The predictive value of the in vitro platelet toxicity assay (iPTA) for the diagnosis of hypersensitivity reactions to sulfonamides.
Elzagallaai AA; Koren G; Rieder MJ
J Clin Pharmacol; 2013 Jun; 53(6):626-32. PubMed ID: 23670648
[TBL] [Abstract][Full Text] [Related]
2. Role of Oxidative Stress in Hypersensitivity Reactions to Sulfonamides.
Elzagallaai AA; Sultan EA; Bend JR; Abuzgaia AM; Loubani E; Rieder MJ
J Clin Pharmacol; 2020 Mar; 60(3):409-421. PubMed ID: 31709574
[TBL] [Abstract][Full Text] [Related]
3. The in vitro platelet toxicity assay (iPTA): a novel approach for assessment of drug hypersensitivity syndrome.
Elzagallaai AA; Rieder MJ; Koren G
J Clin Pharmacol; 2011 Mar; 51(3):428-35. PubMed ID: 20400650
[No Abstract] [Full Text] [Related]
4. Drug Hypersensitivity Reactions in Patients with Cystic Fibrosis: Potential Value of the Lymphocyte Toxicity Assay to Assess Risk.
Abuzgaia AM; Elzagallaai AA; Mullowney T; Rieder MJ
Mol Diagn Ther; 2023 May; 27(3):395-403. PubMed ID: 36939981
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis of sulfonamide hypersensitivity reactions by in-vitro "rechallenge" with hydroxylamine metabolites.
Rieder MJ; Uetrecht J; Shear NH; Cannon M; Miller M; Spielberg SP
Ann Intern Med; 1989 Feb; 110(4):286-9. PubMed ID: 2913915
[TBL] [Abstract][Full Text] [Related]
6. Predictive value of the lymphocyte toxicity assay in the diagnosis of drug hypersensitivity syndrome.
Elzagallaai AA; Jahedmotlagh Z; Del Pozzo-Magaña BR; Knowles SR; Prasad AN; Shear NH; Rieder MJ; Koren G
Mol Diagn Ther; 2010 Oct; 14(5):317-22. PubMed ID: 21053997
[TBL] [Abstract][Full Text] [Related]
7. Toxicity of sulfonamide-reactive metabolites in HIV-infected, HTLV-infected, and noninfected cells.
Rieder MJ; Krause R; Bird IA; Dekaban GA
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Feb; 8(2):134-40. PubMed ID: 7834397
[TBL] [Abstract][Full Text] [Related]
8. Improving the diagnosis of hypersensitivity reactions associated with sulfonamides.
Lanctôt KL; Ghajar BM; Shear NH; Naranjo CA
J Clin Pharmacol; 1994 Dec; 34(12):1228-33. PubMed ID: 7738220
[TBL] [Abstract][Full Text] [Related]
9. Is hydroxylamine-induced cytotoxicity a valid marker for hypersensitivity reactions to sulfamethoxazole in human immunodeficiency virus-infected individuals?
Reilly TP; MacArthur RD; Farrough MJ; Crane LR; Woster PM; Svensson CK
J Pharmacol Exp Ther; 1999 Dec; 291(3):1356-64. PubMed ID: 10565861
[TBL] [Abstract][Full Text] [Related]
10. Predicting possible zonisamide hypersensitivity syndrome.
Neuman MG; Shear NH; Malkiewicz IM; Kessas M; Lee AW; Cohen L
Exp Dermatol; 2008 Dec; 17(12):1045-51. PubMed ID: 18637135
[TBL] [Abstract][Full Text] [Related]
11. Immunopathogenesis of hypersensitivity syndrome reactions to sulfonamides.
Neuman MG; Shear NH; Malkiewicz IM; Taeri M; Shapiro LE; Krivoy N; Haber J; Gomez M; Fish J; Cartotto R; Cohen L
Transl Res; 2007 May; 149(5):243-53. PubMed ID: 17466923
[TBL] [Abstract][Full Text] [Related]
12. A novel lymphocyte toxicity assay to assess drug hypersensitivity syndromes.
Neuman MG; Malkiewicz IM; Shear NH
Clin Biochem; 2000 Oct; 33(7):517-24. PubMed ID: 11124336
[TBL] [Abstract][Full Text] [Related]
13. Adverse reactions to sulphonamide and sulphonamide-trimethoprim antimicrobials: clinical syndromes and pathogenesis.
Cribb AE; Lee BL; Trepanier LA; Spielberg SP
Adverse Drug React Toxicol Rev; 1996 Mar; 15(1):9-50. PubMed ID: 8920632
[No Abstract] [Full Text] [Related]
14. Differential toxicity of reactive metabolites of clindamycin and sulfonamides in HIV-infected cells: influence of HIV infection on clindamycin toxicity in vitro.
Wijsman JA; Dekaban GA; Rieder MJ
J Clin Pharmacol; 2005 Mar; 45(3):346-51. PubMed ID: 15703369
[TBL] [Abstract][Full Text] [Related]
15. The role of
Elzagallaai AA; Abuzgaia AM; Del Pozzo-Magaña BR; Loubani E; Rieder MJ
Front Pharmacol; 2022; 13():945545. PubMed ID: 36110527
[No Abstract] [Full Text] [Related]
16. Drug metabolite-specific lymphocyte responses in sulfamethoxazole allergic patients with cystic fibrosis.
Lavergne SN; Whitaker P; Peckham D; Conway S; Park BK; Naisbitt DJ
Chem Res Toxicol; 2010 Jun; 23(6):1009-11. PubMed ID: 20481640
[TBL] [Abstract][Full Text] [Related]
17. Lymphocyte transformation test and cytokine detection assays: Determination of read out parameters for delayed-type drug hypersensitivity reactions.
Srinoulprasert Y
J Immunol Methods; 2021 Sep; 496():113098. PubMed ID: 34216607
[TBL] [Abstract][Full Text] [Related]
18. Cross-reactivity in drug hypersensitivity reactions to sulfasalazine and sulfamethoxazole.
Zawodniak A; Lochmatter P; Beeler A; Pichler WJ
Int Arch Allergy Immunol; 2010; 153(2):152-6. PubMed ID: 20413982
[TBL] [Abstract][Full Text] [Related]
19. Clinical characteristics of patients with drug hypersensitivity in Norway: a single-centre study.
Chalabianloo F; Berstad A; Schjøtt J; Riedel B; Irgens A; Florvaag E
Pharmacoepidemiol Drug Saf; 2011 May; 20(5):506-13. PubMed ID: 21523851
[TBL] [Abstract][Full Text] [Related]
20. Drug hypersensitivity.
Solensky R
Med Clin North Am; 2006 Jan; 90(1):233-60. PubMed ID: 16310532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
